Clinical Trial Update: Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cardioprotective benefits of adding carvedilol-CR or valsartan to lisinopril in hypertension; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Carvedilol CR (carvedilol)
• Lisinopril (Lisinopril)
• VALSARTAN (Valsartan)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2022-05-27